GRAFT FAILURE
Clinical trials for GRAFT FAILURE explained in plain language.
Never miss a new study
Get alerted when new GRAFT FAILURE trials appear
Sign up with your email to follow new studies for GRAFT FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood filter could be key to saving High-Risk transplant patients
Disease control CompletedThis study looked back at 50 patients with blood cancers or disorders who received a stem cell transplant from a partially matched family donor. Before the transplant, some patients received a special blood-filtering treatment to remove antibodies that could cause the body to rej…
Matched conditions: GRAFT FAILURE
Sponsor: Ting YANG • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Heart transplant patients test simpler daily pill to prevent organ rejection
Disease control CompletedThis study tested if a new, once-daily version of a common anti-rejection drug works as well as the standard twice-daily version for heart transplant patients. It involved 50 adults who had received a heart transplant. The main goal was to see if the simpler, once-a-day pill was …
Matched conditions: GRAFT FAILURE
Phase: PHASE2 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for second kidney transplants: drug aims to stop body from rejecting future grafts
Disease control CompletedThis study tested if a single dose of the drug tocilizumab, given around the time a failed kidney transplant is surgically removed, is safe and can help reduce harmful antibodies. These antibodies often form after removal and make it very difficult for patients to receive a secon…
Matched conditions: GRAFT FAILURE
Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC